Moreover, SOX2 can lead to glioma formation, and SOX2-KO mice demonstrated inhibition of glioblastoma development and tumorigenicity, suggesting that this transcription factor is crucial for the preservation of self-renewal balance (130, 131). Here, SOX2 is linked to central nervous system cancer.